Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
44
OMIC Quote, Financials, Valuation and Earnings
Last price:
$19.36
Seasonality move
:
-26.94%
Day range:
$19.00 - $19.50
52-week range:
$5.34 - $23.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
18.03x
P/B ratio:
0.39x
Volume:
185.8K
Avg. volume:
17.3K
1-year change:
49.65%
Market cap:
$48.6M
Revenue:
$2.9M
EPS (TTM):
-$34.76
Earnings Data
Next earnings date for OMIC
Mar 18
2025
Most recent earnings per share
-$6.72
Beat by $1.14
(Nov 12/2024)
Consensus Estimate
-$7.86
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
OMIC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/18/2025 | Q4 | $1.8M | -- | -- | -$7.85 | -- |
| 11/12/2024 | Q3 | $825K | $406K | -$6.72 | -$7.86 | $1.14 |
| 08/13/2024 | Q2 | $406.5K | $737K | -$8.57 | -$8.95 | $0.38 |
| 05/14/2024 | Q1 | $694K | $442K | -$10.20 | -$9.60 | -$0.60 |
| 03/18/2024 | Q4 | $1M | $1.1M | -$9.27 | -$9.80 | $0.53 |
| 11/14/2023 | Q3 | $1.3M | $462K | -$9.25 | -$11.45 | $2.20 |
| 08/09/2023 | Q2 | $1.1M | $505K | -$10.58 | -$10.84 | $0.26 |
| 05/09/2023 | Q1 | $1.2M | $863K | -$9.90 | -$10.45 | $0.55 |
| 03/02/2023 | Q4 | $733.6K | $765K | -$8.70 | -$12.35 | $3.65 |
| 11/07/2022 | Q3 | -- | -- | -$9.90 | -$11.74 | $1.84 |
| 08/09/2022 | Q2 | -- | -- | -$10.20 | -- | -- |
| 05/10/2022 | Q1 | -- | -- | -$9.30 | -- | -- |
| 03/02/2022 | Q4 | -- | -- | -$8.10 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$7.50 | -- | -- |
| 08/03/2021 | Q2 | -- | -- | -$35.40 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$10.55 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$3.42 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$3.43 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$2.96 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$2.27 | -- | -- |
Singular Genomics Systems Earnings Questions
-
How Much did Singular Genomics Systems Generate in Revenue Last Quarter?
Singular Genomics Systems reported $406K worth of top line sales in its most recent quarter.
-
Did Singular Genomics Systems Beat Earnings Last Quarter?
Singular Genomics Systems announced earnings per share of -$6.72 which represents a beat of analyst forecast a -$7.86 per share.
-
Is Singular Genomics Systems Profitable?
Singular Genomics Systems reported -$301K that represents -$0.12 per share over the last quarter.
-
What is the Analyst Consensus for Singular Genomics Systems EPS Next Year?
Singular Genomics Systems's earnings are forecast to decrease from -$39.00 per share to -$37.93 per share next year representing a decrease of -11.67%.
-
When is Singular Genomics Systems's Earnings Date?
Singular Genomics Systems's next earnings date is March 18, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
52
TSLL alert for Dec 24
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
31
SOXL alert for Dec 24
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.
